SCHEMBL5063148

SCHEMBL5063148

COc1cc2c(cc1OC(F)F)C1CC(O)CCC1N=C2c1ccc(NS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.65
KMT2A Q03164 6/20 0.45
LMNA P02545 5/20 0.45
MEN1 O00255 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
HPGD P15428 1/20 0.45
PDE4B Q07343 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4C Q08493 1/20 0.38
GHSR Q92847 1/20 0.37
MAPT P10636 5/20 0.37
GAA P10253 2/20 0.37
ALDH1A1 P00352 4/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
NR2F2 P24468 1/20 0.36
NOD2 Q9HC29 1/20 0.36
KDM4E B2RXH2 1/20 0.35
JAK1 P23458 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064551 1.00 PDE4D (0.65) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL5058868 0.94 PDE4D (0.72) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL5064542 0.94 PDE4D (0.57) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL5063387 0.89 PDE4D (0.49) PDE4DSMN1; SMN2PDE4BPDE4APDE4C
SCHEMBL5066759 0.89 PDE4D (0.62) PDE4DKMT2ALMNANPSR1HPGD
SCHEMBL5063197 0.89 PDE4D (0.53) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL5058925 0.89 PDE4D (0.53) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL5058936 0.84 PDE4D (0.58) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL7704337 0.83 PDE4D (0.77) PDE4DKMT2ALMNAMEN1SMN1; SMN2
SCHEMBL7704339 0.83 PDE4D (0.77) PDE4DKMT2ALMNAMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-07-03 US claimed
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161339-A1 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE4C PDE4D 4/4885KMT2A 1874/4885LMNA 4788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.